Correlation Between Mallinckrodt Plc and Aquestive Therapeutics
Can any of the company-specific risk be diversified away by investing in both Mallinckrodt Plc and Aquestive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mallinckrodt Plc and Aquestive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mallinckrodt Plc and Aquestive Therapeutics, you can compare the effects of market volatilities on Mallinckrodt Plc and Aquestive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mallinckrodt Plc with a short position of Aquestive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mallinckrodt Plc and Aquestive Therapeutics.
Diversification Opportunities for Mallinckrodt Plc and Aquestive Therapeutics
0.1 | Correlation Coefficient |
Average diversification
The 3 months correlation between Mallinckrodt and Aquestive is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Mallinckrodt Plc and Aquestive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aquestive Therapeutics and Mallinckrodt Plc is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mallinckrodt Plc are associated (or correlated) with Aquestive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aquestive Therapeutics has no effect on the direction of Mallinckrodt Plc i.e., Mallinckrodt Plc and Aquestive Therapeutics go up and down completely randomly.
Pair Corralation between Mallinckrodt Plc and Aquestive Therapeutics
Considering the 90-day investment horizon Mallinckrodt Plc is expected to generate 7.73 times more return on investment than Aquestive Therapeutics. However, Mallinckrodt Plc is 7.73 times more volatile than Aquestive Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Aquestive Therapeutics is currently generating about 0.08 per unit of risk. If you would invest 836.00 in Mallinckrodt Plc on September 14, 2024 and sell it today you would lose (790.00) from holding Mallinckrodt Plc or give up 94.5% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 29.09% |
| Values | Daily Returns |
Mallinckrodt Plc vs. Aquestive Therapeutics
Performance |
| Timeline |
| Mallinckrodt Plc |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Aquestive Therapeutics |
Mallinckrodt Plc and Aquestive Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mallinckrodt Plc and Aquestive Therapeutics
The main advantage of trading using opposite Mallinckrodt Plc and Aquestive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mallinckrodt Plc position performs unexpectedly, Aquestive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aquestive Therapeutics will offset losses from the drop in Aquestive Therapeutics' long position.| Mallinckrodt Plc vs. Lifecore Biomedical | Mallinckrodt Plc vs. Shuttle Pharmaceuticals | Mallinckrodt Plc vs. Organogenesis Holdings | Mallinckrodt Plc vs. Journey Medical Corp |
| Aquestive Therapeutics vs. Evoke Pharma | Aquestive Therapeutics vs. Dynavax Technologies | Aquestive Therapeutics vs. Amphastar P | Aquestive Therapeutics vs. Lantheus Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |